{
    "code": "10000828",
    "time": "2015-07-24 03:54:10",
    "許可證字號": "衛署菌疫輸字第000828號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "105\/10\/02",
    "發證日期": "95\/10\/02",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA01000082801",
    "中文品名": "\"瑞士\" 宜保利血注射液40000單位\/公撮",
    "英文品名": "Eprex Injection 40000 IU\/ml",
    "適應症": "治療與慢性腎臟功能失調有關的貧血症狀或因此而需要輸血的患者、治療與癌症化學治療有關的症狀性貧血。",
    "劑型": "270注射劑",
    "包裝": "0.5ml (20000IU)注射針筒，含針頭防刺\/護裝置 ( Passive Needle Guard ) 1.0ml (40000IU)注射針筒，含針頭防刺\/護裝置 ( Passive Needle Guard ) 100支以下盒裝",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "EPOETIN ALFA",
    "限制項目": [
        "02輸入",
        "1D須執行風險管理計畫"
    ],
    "申請商名稱": "1507401100  嬌生股份有限公司",
    "申請商地址": "台北市大安區敦化南路二段319號4、5樓",
    "主製造廠": {
        "製造廠名稱": "F430263000  CILAG AG",
        "製造廠廠址": "HOCHSTRASSE 201, CH-8200 SCHAFFHAUSEN, SWITZERLAND",
        "製造廠公司地址": "",
        "製造廠國別": "SWITZERLAND",
        "製程": "製造、包裝"
    },
    "CCC號列": "30049020007 血液代用品與血漿代用品及基因重組製劑Substitutes of blood, substitutes of plasma and preparationsof gennetic recombinants",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1600001200",
            "成分名稱": "EPOETIN ALFA",
            "含量描述": "",
            "含量": "0.3360000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 瑞士宜保利血注射液-INS-040518-104-06-10.pdf 楊森瑞士宜保利血仿單1002-01___20110121.jpg Eprex Injection 40000 IU英文仿單擬稿___20120803.pdf Eprex Injection 40000 IU中文仿單擬稿___20120803.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=10000828&Seq=004&Type=9"
        }
    ]
}